The indicator assesses the willingness of the initiative/project to collaborate and share intellectual property with other research institutions to generate more advanced and improved research outputs with the capacity to generate an impact on patients' wellbeing. Sharing intellectual property can accelerate the development of new products and treatments to maximize their potential.